ESRP1 and Insulin resistance: Although there is no reported connection to COVID-19, altered expression of key spliceosome components, including ESRP1, has been mentioned in relation to miR-4454, a microRNA associated with insulin resistance in obesity [43], as well as with caspase-independent cell death [44].